Cushing syndrome in the McCune-Albright syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 4, 2010, Pages 1508-1515

  Brown, Rebecca J ^a   Kelly, Marilyn H ^b   Collins, Michael T ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ADRENALECTOMY; ALBRIGHT SYNDROME; ARTICLE; CHILD; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; CUSHING SYNDROME; FAILURE TO THRIVE; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFANT; LIVER DISEASE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MOON FACE; MORTALITY; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; TERTIARY HEALTH CARE; ADRENAL GLAND; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; ONSET AGE; PATHOPHYSIOLOGY; SMALL FOR DATE INFANT; URINE;

ADRENAL GLANDS; ADRENALECTOMY; AGE OF ONSET; CASE-CONTROL STUDIES; CUSHING SYNDROME; DISEASE PROGRESSION; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; HEART DISEASES; HUMANS; HYDROCORTISONE; INFANT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LIVER DISEASES; MALE; PROGNOSIS;

EID: 77951625303     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2321     Document Type: Article

References (38)

1. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695
2. Schwindinger WF, Francomano CA, Levine MA 1992 Identification of a mutation in the gene encoding the α subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152-5156
3. Dumitrescu CE, Collins MT 2008 McCune-Albright syndrome. Orphanet J Rare Dis 3:12
4. Feuillan PP 1997 McCune-Albright syndrome. Curr Ther Endocrinol Metab 6:235-239
5. Diaz A, Danon M, Crawford J 2007 McCune-Albright syndrome and disorders due to activating mutations of GNAS1. J Pediatr Endocrinol Metab 20:853-880 (Pubitemid 47455346)
6. Zacharin M 2007 The spectrum of McCune Albright syndrome. Pediatr Endocrinol Rev 4(Suppl 4):412-418
7. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG 2001 Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16:806-813 (Pubitemid 32332290)
8. Silva ES, Lumbroso S, Medina M, Gillerot Y, Sultan C, Sokal EM 2000 Demonstration of McCune-Albright mutations in the liver of children with high γ GT progressive cholestasis. J Hepatol 32: 154-158 (Pubitemid 30039460)
9. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM 1993 Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 123:509-518
10. Ringel MD, Schwindinger WF, Levine MA 1996 Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine (Baltimore) 75:171-184
11. Kirk JM, Brain CE, Carson DJ, Hyde JC, Grant DB 1999 Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 134:789-792
12. Aarskog D, Tveteraas E 1968 McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancy. J Pediatr 73:89-96
13. Bareille P, Azcona C, Stanhope R 1999 Multiple neonatal endocrinopathies in McCune-Albright syndrome. J Paediatr Child Health 35:315-318
14. Boston BA, Mandel S, La Franchi S, Bliziotes M 1994 Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 79:890-893
15. Brogan P, Khadilkar VV, Stanhope R 1998 Occult T3 toxicosis in McCune-Albright syndrome. Horm Res 50:105-106
16. Danon M, Robboy SJ, Kim S, Scully R, Crawford JD 1975 Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. J Pediatr 87:917-921
17. Davies JH, Barton JS, Gregory JW, Mills C 2001 Infantile McCune-Albright syndrome. Pediatr Dermatol 18:504-506
18. Halioui-Louhaichi S, Azzabi O, Nefzi L, Ben Hariz M, Ben Mrad N, Ben Ammar B, Maherzi A 2005 [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome]. Arch Pediatr 12:1120-1123
19. Kessel D, Hall CM, Shaw DG 1992 Two unusual cases of nephrocalcinosis in infancy. Pediatr Radiol 22:470-471
20. Lala R, Matarazzo P, Andreo M, Defilippi C, de Sanctis C 2002 Impact of endocrine hyperfunction and phosphate wasting on bone in McCune-Albright syndrome. J Pediatr Endocrinol Metab 15(Suppl 3):913-920
21. Listernick R 2004 A 14-week-old girl with severe respiratory distress, hyperpigmentation. Pediatr Ann 33:218-222 (Pubitemid 38456545)
22. Mauras N, Blizzard RM 1986 The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh) 279:207-217
23. Post EM CL, Hitch I, Oliphant M, Dracker R, Richman RA 1983 Congenital Cushing syndrome with polyostotic fibrous dysplasia. Pediatr Res 17:169A
24. Yoshimoto M, Nakayama M, Baba T, Uehara Y, Niikawa N, Ito M, Tsuji Y 1991 A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand 80: 984-987
25. Benjamin DR, McRoberts JW 1973 Polyostotic fibrous dysplasia associated with Cushing syndrome. Arch Pathol 96:175-178
26. Fragoso MC, Domenice S, Latronico AC, Martin RM, Pereira MA, Zerbini MC, Lucon AM, Mendonca BB 2003 Cushing's syndrome secondary to adrenocorticotropin- independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 88:2147-2151
27. Bocian-Sobkowska J, Malendowicz LK, Wo Ÿniak W 1997 Comparative stereological study on zonation and cellular composition of adrenal glands of normal and anencephalic human fetuses. I. Zonation of the gland. Histol Histopathol 12:311-317
28. Breault L, Chamoux E, Lehoux JG, Gallo-Payet N 2000 Localization of G protein α-subunits in the human fetal adrenal gland. Endocrinology 141:4334-4341 (Pubitemid 32055106)
29. Bocian-Sobkowska J, Wo Ÿniak W, Malendowicz LK 1998 Postnatal involution of the human adrenal fetal zone: stereologic description and apoptosis. Endocr Res 24:969-973 (Pubitemid 29016510)
30. Shriberg LD, Aram DM, Kwiatkowski J 1997 Developmental apraxia of speech. I. Descriptive and theoretical perspectives. J Speech Lang Hear Res 40:273-285
31. Keil MF, Merke DP, Gandhi R, Wiggs EA, Obunse K, Stratakis CA 2009 Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study. Clin Endocrinol (Oxf) 71: 326-333
32. Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI 2004 Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J Clin Endocrinol Metab 89:610-614
33. Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S 2007 Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab 92:542-548
34. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, Harding JE 2005 Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 331:665
35. Crowley PA 1995 Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 173: 322-335
36. Bourtchouladze R, Patterson SL, Kelly MP, Kreibich A, Kandel ER, Abel T 2006 Chronically increased Gsα signaling disrupts associative and spatial learning. Learn Mem 13:745-752
37. Kelly MP, Cheung YF, Favilla C, Siegel SJ, Kanes SJ, Houslay MD, Abel T 2008 Constitutive activation of the G-protein subunit Gαs within forebrain neurons causes PKA-dependent alterations in fear conditioning and cortical Arc mRNA expression. Learn Mem 15:75-83
38. Kelly MP, Isiegas C, Cheung YF, Tokarczyk J, Yang X, Esposito MF, Rapoport DA, Fabian SA, Siegel SJ, Wand G, Houslay MD, Kanes SJ, Abel T 2007 Constitutive activation of Gαs within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP. Neuropsychopharmacology 32: 577-588